Fas Ligand (FasL, Apo-1L/CD95L) Expression and Clinical Outcome in Papillary Microcarcinoma and Papillary Thyroid Carcinomas with Diameter Smaller than 1.5 Centimeters

Tarih
2010
Yazar
Kapran, Y.
Bayraktaroglu, T.
Tanakol, R.
Alagoel, F.
Boztepe, H.
Üst veri
Tüm öğe kaydını göster
Özet
Context: The presence and the importance of FasL (FasL, APO-1L/CD95L) in papillary microcarcinoma lesions which are smaller than 1.5 cm of the thyroid is unclear.
Bağlantı
http://hdl.handle.net/20.500.12627/92573
https://doi.org/10.1055/s-0029-1241205
Koleksiyonlar